FYCO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.405600E-01
Normal-vs-Stage2
4.603800E-01
Normal-vs-Stage3
7.220500E-03
Normal-vs-Stage4
3.737600E-01
Stage1-vs-Stage2
5.300600E-01
Stage1-vs-Stage3
2.360100E-02
Stage1-vs-Stage4
2.196800E-01
Stage2-vs-Stage3
8.337500E-02
Stage2-vs-Stage4
7.749600E-02
Stage3-vs-Stage4
3.642800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.275400E-01
Normal-vs-AfricanAmerican
4.689000E-01
Normal-vs-Asian
4.015600E-01
Caucasian-vs-AfricanAmerican
9.780600E-01
Caucasian-vs-Asian
6.419400E-01
AfricanAmerican-vs-Asian
7.779600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.980800E-01
Normal-vs-Female
4.700400E-01
Male-vs-Female
9.102000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.303800E-01
Normal-vs-Age(41-60Yrs)
5.892200E-01
Normal-vs-Age(61-80Yrs)
4.071200E-01
Normal-vs-Age(81-100Yrs)
1.038760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.870200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.240600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.184800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.723150E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.419700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.745250E-01
Normal-vs-Daily Drinker
6.704100E-02
Normal-vs-Weekly Drinker
4.953200E-01
Normal-vs-Occasional Drinker
3.850400E-01
Normal-vs-Social Drinker
9.927400E-01
Non Drinker-vs-Daily Drinker
4.685200E-01
Non Drinker-vs-Weekly Drinker
5.216000E-01
Non Drinker-vs-Occasional Drinker
4.232200E-01
Non Drinker-vs-Social Drinker
1.807050E-01
Daily Drinker-vs-Weekly Drinker
2.570600E-01
Daily Drinker-vs-Occasional Drinker
1.580810E-01
Daily Drinker-vs-Social Drinker
1.016580E-01
Weekly Drinker-vs-Occasional Drinker
9.819600E-01
Weekly Drinker-vs-Social Drinker
4.034800E-01
Occasional Drinker-vs-Social Drinker
3.653600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.410500E-02
Normal-vs-Grade 2
3.076100E-02
Normal-vs-Grade 3
3.600200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.684800E-01
Grade 1-vs-Grade 3
7.326600E-01
Grade 1-vs-Grade 4
7.410500E-02
Grade 2-vs-Grade 3
4.057600E-01
Grade 2-vs-Grade 4
3.076100E-02
Grade 3-vs-Grade 4
3.600200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.636400E-01
Normal-vs-NonDiabetic
2.373200E-01
Diabetic-vs-NonDiabetic
3.813600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.387400E-01
Normal-vs-NoPancreatitis
2.649800E-01
Pancreatitis-vs-NoPancreatitis
4.839800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.814200E-01
Normal-vs-N1
4.502800E-01
N0-vs-N1
7.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.185400E-01
Normal-vs-TP53-NonMutant
7.508800E-01
TP53-Mutant-vs-TP53-NonMutant
1.467160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
